bone marrow derived autologous cd34+ selected cells
Cell therapyexperimental
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
1
Earliest trial started Mar 1, 2006 (NCT00313339)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 1 Sponsor(trial)
Indications
Approved for
Mechanism of action
- Bone marrowTissue restoration
bone marrow - tissue restoration
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- bone marrow derived autologous cd34+ selected cells
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04243681 | Phase 4 | Jul 1, 2019 | Asian Institute of Gastroenterology |
| NCT00313339 | Phase 1 | Mar 1, 2006 | Emory University, Texas Heart Institute |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Asian Institute of Gastroenterology | Academic/Hospital | 1 | 1 | 1 | 2019 |
| Emory University | Academic/Hospital | 1 | 1 | 1 | 2006 |
| Texas Heart Institute | Academic/Hospital | 1 | 0 | 1 | 2006 |
3 organizations
Page 1 / 1